series-c-plus
Stage
1
Investors
About
LumaCyte develops an imaging-based, microfluidic single-cell analysis platform (an advanced flow cytometry instrument) for high-throughput cell characterization to support cell therapy development, bioprocessing, and biological research.
Explore LumaCyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.